CpG‐enhanced CD8+ T‐cell responses to peptide immunization are severely inhibited by B cells

Open Access
Publisher Website
Google Scholar
Abstract
Synthetic peptides encoding protective pathogen‐derived epitopes represent – in principle – an ideal approach to T‐cell vaccination. Empirically, however, these strategies have not been successful. In the current study, we profiled the early activation of CD8+ T cells by MHC class I‐restricted peptide immunization to better understand the biology of this response. We found that CD8+ T cells proliferated robustly in response to low doses of short synthetic peptides in PBS, but failed to acquire effector function or form memory populations in the absence of the TLR ligand CpG. CpG was unique among TLR ligands in its ability to enhance the response to peptide and its adjuvant effects had strict temporal requirements. Interestingly, CpG treatment modulated T‐cell expression of the surface receptors PD‐1 and CD25, providing insight into its possible adjuvant mechanism. The effects of CpG on peptide immunization were dramatically enhanced in the absence of B cells, demonstrating a unique system of regulation of T‐cell responses by these lymphocytes. The results reported here provide insight into the complex response to a simple vaccination regimen, as well as a framework for a rational peptide‐based vaccine design to both exploit and overcome targeted aspects of the immune response.